Laboratory Tests for Evaluating an Inflamed Liver
The initial laboratory panel for evaluating liver inflammation should include: ALT, AST, alkaline phosphatase (ALP), bilirubin, albumin, and gamma-glutamyltransferase (GGT), along with a complete blood count if not performed within the past 12 months 1.
Core Initial Laboratory Panel
The following tests form the foundation of liver inflammation assessment:
Hepatocellular Injury Markers
- ALT (Alanine Aminotransferase): Most specific for liver injury, as it has low concentrations in other tissues. Normal values are 29-33 IU/L for males and 19-25 IU/L for females 2, 3
- AST (Aspartate Aminotransferase): Less specific than ALT, as it can be elevated in cardiac, skeletal muscle, kidney, and brain disorders 2
- AST:ALT ratio: Helps differentiate causes—ratio >2 suggests alcohol-induced liver disease, while <1 suggests metabolic/fatty liver disease 2
Cholestatic Markers
- Alkaline Phosphatase (ALP): Elevated in cholestatic liver disease and bile flow obstruction 2
- GGT (Gamma-Glutamyltransferase): Confirms hepatic origin when ALP is elevated in isolation 1
Liver Function Markers
- Bilirubin (total): Should be fractionated into conjugated and unconjugated if elevated. Conjugated hyperbilirubinemia indicates parenchymal liver disease or biliary obstruction 1
- Albumin: Reflects synthetic function, though it can be reduced in sepsis, inflammatory disorders, nephrotic syndrome, and malabsorption 1
- Prothrombin Time (PT)/INR: Assesses clotting factor production; prolongation indicates significant liver injury (>70% loss of synthetic function) or vitamin K deficiency 1
Additional Baseline Test
- Complete Blood Count: Thrombocytopenia is the most common hematological abnormality in chronic liver disease and indicates advanced disease with portal hypertension 1
Standard Liver Etiology Screen
Once abnormal liver tests are identified, proceed with a comprehensive etiology screen regardless of the degree or duration of abnormality 1:
Infectious Causes
- Hepatitis B surface antigen
- Hepatitis C antibody (with PCR if positive)
Autoimmune Causes
- Anti-mitochondrial antibody
- Anti-smooth muscle antibody
- Antinuclear antibody
- Serum immunoglobulins
Metabolic Causes
- Ferritin and transferrin saturation (measured simultaneously) for hemochromatosis screening
Imaging
- Abdominal ultrasound: First-line imaging to detect steatosis, biliary obstruction, and structural abnormalities 2, 1
Severity Classification by Aminotransferase Elevation
The degree of elevation guides urgency and differential diagnosis 2:
- Mild: <5 times upper reference limit
- Moderate: 5-10 times upper reference limit
- Severe: >10 times upper reference limit
For severe elevations (ALT >1000 U/L), consider acute viral hepatitis (hepatitis A, E, cytomegalovirus) in addition to the standard workup 1.
Pediatric Modifications
In children, the etiology panel differs 1:
- Add: Anti-liver kidney microsomal antibody, coeliac antibodies, alpha-1-antitrypsin level, and caeruloplasmin (age >3 years)
- Ferritin and transferrin saturation may not be indicated
- Urgent referral required if conjugated bilirubin >25 μmol/L in neonates/infants
Critical Interpretation Points
The extent of abnormality does not necessarily indicate clinical significance—context matters 1. Interpret results only after reviewing:
- Previous laboratory results
- Past medical history
- Current medical condition
- Medication history (prescribed, over-the-counter, herbal)
- Alcohol intake
- Metabolic syndrome features (obesity, hypertension, diabetes, dyslipidemia)
Common Pitfalls to Avoid
- Isolated elevated bilirubin: Most commonly Gilbert's syndrome if predominantly unconjugated and no hemolysis 1
- Isolated elevated ferritin: Often reflects dysmetabolic iron overload in NAFLD or alcohol excess, not hemochromatosis—requires elevated transferrin saturation >45% for hemochromatosis diagnosis 1
- Elevated AST without ALT elevation: Consider non-hepatic causes including hemolysis, myopathy, thyroid disease, or exercise 2
- Isolated ALP elevation: Measure GGT to confirm hepatic origin versus bone disease 1
This algorithmic approach ensures systematic evaluation while avoiding unnecessary testing and correctly identifying treatable causes of liver inflammation.